13th International Conference on Malignant Lymphoma
Pembrolizumab takes on r/r PMBCL
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – Patients with relapsed/refractory primary mediastinal large ...
Avelumab induces response in Hodgkin lymphoma after failed allo-SCT
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – The immune checkpoint inhibitor avelumab showed ...
- 13th International Conference on Malignant Lymphoma
- Conference News
- Frontline Medical News
- New Drugs
- Oncology
Tazemetostat active against follicular lymphoma with EZH2 mutation
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – Tazemetostat, a first-in-class experimental agent that ...
Ibrutinib/buparlisib looks good for relapsed mantle cell lymphoma
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – A combination of the Bruton’s tyrosine ...
Pembrolizumab + rituximab boost response rates in relapsed follicular lymphoma
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – A novel combination of the anti-programmed ...
Lenalidomide-rituximab induces high CR rate in untreated follicular lymphoma
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – The chemotherapy-free combination of lenalidomide (Revlimid) ...
Sequential triple therapy produces high response rates in CLL
AT 14-ICML Lugano, Switzerland (FRONTLINE MEDICAL NEWS)– It’s in the BAG: For patients with ...
GALEN safe and effective in relapsed and refractory follicular lymphoma
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – For patients with relapsed or refractory ...
- 13th International Conference on Malignant Lymphoma
- Conference News
- Frontline Medical News
- New Drugs
- Oncology
Len plus anti-CD19 Mab MOR208 active against advanced DLBCL
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – Combining lenalidomide (Revlimid) with an anti-CD19 ...
- 13th International Conference on Malignant Lymphoma
- Conference News
- Frontline Medical News
- New Drugs
- Oncology
Hitting BTK, PI3K pays off in B-cell malignancies
AT 14-ICML LUGANO, SWITZERLAND (FRONTLINE MEDICAL NEWS) – A combination of ibrutinib and umbralisib, ...
Index discriminates prognostic groups in CLL
FROM 13-ICML An international prognostic index for patients with chronic lymphocytic leukemia (CLL) may ...
RBAC500 safe, effective for elderly patients with mantle cell lymphoma
FROM 13-ICML Reducing the dose of cytarabine from 800 mg/m2 to 500 mg/m2 allowed ...
Autologous, allogeneic stem-cell transplants in T-cell lymphoma yield similar survival
FROM 13-ICML A randomized trial designed to compare autologous to allogeneic stem cell transplantation ...
- 1
- 2
